Serial Number | 88149322 |
Word Mark | JULVIO |
Filing Date | Wednesday, October 10, 2018 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, November 2, 2020 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, August 6, 2019 |
Goods and Services | Pharmaceutical preparations for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medicinal preparations for cardiac disease, namely, single ventricle heart disease (SVHD); pharmaceuticals, namely, drugs for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation |
Goods and Services | Educational services, namely, lectures, seminars, training and classes in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; education, namely, lectures, seminars, classes and training in the use of pharmaceuticals for cardiac and other health issues |
Goods and Services | Medical and pharmaceutical research for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing and screening services, namely, providing medical testing services and information in the field of the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; conducting clinical trials for others |
Goods and Services | Medical testing and screening services, namely, medical diagnostic testing services and medical screening the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, October 19, 2018 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
US Class Codes | 100, 101, 107 |
Class Status Code | 6 - Active |
Class Status Date | Friday, October 19, 2018 |
Primary Code | 041 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, October 19, 2018 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | NOT AVAILABLE |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Mezzion Pharma Co., Ltd. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | Seoul 06167 KR |
Party Name | Mezzion Pharma Co., Ltd. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Seoul 06167 KR |
Event Date | Event Description |
Monday, November 2, 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Monday, November 2, 2020 | ABANDONMENT - NO USE STATEMENT FILED |
Friday, April 3, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, April 1, 2020 | EXTENSION 1 GRANTED |
Wednesday, April 1, 2020 | EXTENSION 1 FILED |
Wednesday, April 1, 2020 | TEAS EXTENSION RECEIVED |
Tuesday, October 1, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, August 6, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, August 6, 2019 | PUBLISHED FOR OPPOSITION |
Wednesday, July 17, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Monday, July 1, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, June 21, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, June 21, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, June 19, 2019 | ASSIGNED TO LIE |
Friday, June 14, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, January 24, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, January 24, 2019 | NON-FINAL ACTION E-MAILED |
Thursday, January 24, 2019 | NON-FINAL ACTION WRITTEN |
Tuesday, January 22, 2019 | ASSIGNED TO EXAMINER |
Friday, October 19, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Saturday, October 13, 2018 | NEW APPLICATION ENTERED IN TRAM |